Sharma S K, Forgione H, Isaacs J H
Department of Obstetrics and Gynecology, Loyola University Medical Center, Maywood, IL 60153.
Cancer. 1991 May 15;67(10):2467-71. doi: 10.1002/1097-0142(19910515)67:10<2467::aid-cncr2820671013>3.0.co;2-k.
Twenty-one patients with the diagnosis of recurrent gynecologic pelvic malignancy from various primary sites were treated with iodine-125 (I-125) interstitial implants. Eighteen of these patients had been treated with a combination of surgery and radiation therapy for their primary malignancies and 90% had responded. Seventy-five percent had complete local responses. The overall survival time, volume-response relationship, and complications are discussed and the radioresponse of various histologic types is presented.
21例诊断为复发性妇科盆腔恶性肿瘤（原发部位各异）的患者接受了碘-125（I-125）组织间植入治疗。其中18例患者曾接受手术和放射治疗联合治疗其原发性恶性肿瘤，90%有反应。75%有完全局部反应。讨论了总生存时间、体积反应关系和并发症，并给出了各种组织学类型的放射反应。
Zotero 插件